Brief: Keros Therapeutics Announces Update On The Phase 2 Tropos Trial

Keros Therapeutics

12/12/2024 11:40

Dec 12 (Reuters) - Keros Therapeutics Inc  KROS.O :
    * KEROS THERAPEUTICS ANNOUNCES UPDATE ON THE PHASE 2 TROPOS
TRIAL
    * KEROS THERAPEUTICS INC - HALTS DOSING IN 3.0 MG/KG AND 4.5
MG/KG
ARMS IN TROPOS TRIAL
    * KEROS THERAPEUTICS INC - DOSING IN 1.5 MG/KG ARM OF TROPOS
TRIAL
REMAINS ONGOING
    * KEROS THERAPEUTICS INC - EXPECTS TO PRESENT TOPLINE DATA
FROM
ALL TREATMENT ARMS IN TRIAL Q2 2025

Source text:  ID:nGNX5sDHlJ 
Further company coverage:  KROS.O 

 ((Reuters.Briefs@thomsonreuters.com;))